Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Punee Pitisuttithum"'
Autor:
Punee Pitisuttithum, Rosario Z. Capeding, Keith P. Ramsey, Daphne C. Sawlwin, Timo Vesikari, Janine Oberye, Esther Heijnen, Bin Zhang, Igor Smolenov
Publikováno v:
Vaccine. 38:8224-8231
Background Pediatric adjuvanted seasonal influenza vaccines induce higher immune responses and have the potential to confer better protection against influenza among young vaccine-naive children. Limited data describe benefits and risks of repeated a
Autor:
Ricardo Manalastas, Katie Matys, Oliver Bautista, Sara Mallary, Alfred J. Saah, Punee Pitisuttithum, Scott Vuocolo
Publikováno v:
Clinical and Vaccine Immunology. 19:881-885
The exploratory immunogenicity objective of this analysis was to characterize the titer of vaccine human papillomavirus (HPV)-type immunoglobulins in both peripartum maternal blood and the cord blood of infants born to women who received blinded ther
Autor:
Miguel Aste-Amezaga, Vladimir Novitsky, John W. Shiver, Bernard Mbewe, T. Christopher Mast, Walter L. Straus, Punee Pitisuttithum, Swati B. Gupta, Alexander Nikas, Nathan D. Wolfe, Paul Coplan, Danilo R. Casimiro, Lisa Kierstead, Esper G. Kallas, Eftyhia Vardas, Mauro Schechter
Publikováno v:
Vaccine. 28:950-957
Replication-defective adenoviruses have been utilized as candidate HIV vaccine vectors. Few studies have described the international epidemiology of pre-existing immunity to adenoviruses. We enrolled 1904 participants in a cross-sectional serological
Autor:
Damrong Tresukosol, Frank J. Taddeo, Oliver Bautista, Ricardo Manalastas, Eliav Barr, Evan R. Myers, Joseph Monsonego, Punee Pitisuttithum, Janine T. Bryan, Scott Vuocolo, Joaquín Luna, Kevin A. Ault, Richard M. Haupt, Sara Hood, Nubia Muñoz, Mark T. Esser, Christine Clavel, Alfred J. Saah
Publikováno v:
The Lancet. 373:1949-1957
Summary Background Although the peak incidence of human papillomavirus (HPV) infection occurs in most populations within 5–10 years of first sexual experience, all women remain at risk for acquisition of HPV infections. We tested the safety, immuno
Autor:
John W. Shiver, Bernard Mbewe, Romnie Long, Punee Pitisuttithum, Swati B. Gupta, Walter L. Straus, Robin Mogg, Danilo R. Casimiro, Vlad Novitsky, Christopher T. Mast, Kiersten Anderson, Jon H. Condra, Nathan D. Wolfe, Eftyhia Vardas, Sheri Dubey, Paul Coplan, Esper G. Kallas, Donald S. Burke, Mauro Schechter, Dan C. Freed
Publikováno v:
Repositório Institucional da UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
An effective HIV type 1 (HIV-1) vaccine will likely require elicitation of broadly reactive cell-mediated immune (CMI) responses against divergent HIV-1 clades. We compared anti-HIV-1 T-cell immune responses among 363 unvaccinated adults infected wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae8749cf8cb1327fa4149482170a6f25
http://repositorio.unifesp.br/handle/11600/28921
http://repositorio.unifesp.br/handle/11600/28921